Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.

COX

Cox Communications (COX)

Cox Comm CL A SC23
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NYSE:COX
DatumZeitQuelleÜberschriftSymbolFirma
15/06/201515h50Dow Jones NewsCox Automotive to Buy Dealertrack for $3.5 BillionNYSE:COXCox Comm CL A SC23
28/04/201500h10Dow Jones NewsTime Warner Cable Adviser Contacts Rival Cox--UpdateNYSE:COXCox Comm CL A SC23
17/04/201507h42GlobeNewswire Inc.Nicox first quarter 2015 financial and business updateNYSE:COXCox Comm CL A SC23
30/03/201507h40GlobeNewswire Inc.Nicox 2014 Financial Results and Business UpdateNYSE:COXCox Comm CL A SC23
19/03/201507h37GlobeNewswire Inc.Nicox receives Orphan Drug Designation from FDA for naproxcinod in Duchenne Muscular DystrophyNYSE:COXCox Comm CL A SC23
02/02/201507h41GlobeNewswire Inc.Nicox signs exclusive license agreement with InSite Vision for AzaSite(R) and BromSite(TM) in EuropeNYSE:COXCox Comm CL A SC23
26/01/201507h35GlobeNewswire Inc.Nicox holds successful pre-NDA meeting with FDA on AC-170 clinical packageNYSE:COXCox Comm CL A SC23
17/07/201407h36GlobeNewswire Inc.Nicox gains expanded North American rights for Sjo(TM) from Immco DiagnosticsNYSE:COXCox Comm CL A SC23
10/07/201407h35GlobeNewswire Inc.Nicox focuses US operations on national launches of Sjo(TM) and RetnaGene(TM) and restructures RPS(R) licensing agreementNYSE:COXCox Comm CL A SC23
02/07/201407h38GlobeNewswire Inc.Nicox to acquire Aciex Therapeutics, Inc.NYSE:COXCox Comm CL A SC23
30/06/201407h36GlobeNewswire Inc.Nicox launches commercial operations in GermanyNYSE:COXCox Comm CL A SC23
19/06/201407h38GlobeNewswire Inc.Nicox and Sequenom announce the launch of expanded access to RetnaGene(TM) test portfolio in the U.S.NYSE:COXCox Comm CL A SC23
30/05/201407h35GlobeNewswire Inc.CORRECTED RELEASE - Nicox: Santen grants Eupharmed extension of exclusive rights to distribute Cationorm(R) in ItalyNYSE:COXCox Comm CL A SC23
28/05/201407h36GlobeNewswire Inc.Nicox: Santen grants Eupharmed extension of exclusive rights to distribute Cationorm(R) in ItalyNYSE:COXCox Comm CL A SC23
15/05/201417h49GlobeNewswire Inc.Nicox: first quarter 2014 financial informationNYSE:COXCox Comm CL A SC23
02/04/201407h41GlobeNewswire Inc.Nicox 2013 Financial Results and Business UpdateNYSE:COXCox Comm CL A SC23
17/03/201407h35GlobeNewswire Inc.Nicox launches AdenoPlus(R) and Xailin(TM) dry eye product range in EuropeNYSE:COXCox Comm CL A SC23
14/02/201407h34GlobeNewswire Inc.Nicox to re-focus naproxcinod on Duchenne muscular dystrophyNYSE:COXCox Comm CL A SC23
04/02/201407h41GlobeNewswire Inc.Nicox appoints Evelyne Nguyen as CFONYSE:COXCox Comm CL A SC23
16/01/201407h37GlobeNewswire Inc.Sequenom Laboratories grants Nicox exclusive promotion and marketing rights for its RetnaGene(TM) AMD test in North AmericaNYSE:COXCox Comm CL A SC23
06/01/201423h39Dow Jones NewsConvergys Agrees to Acquire Stream Global ServicesNYSE:COXCox Comm CL A SC23
06/01/201407h34GlobeNewswire Inc.Nicox - Major Progress in 2013 in Building an International Ophthalmic CompanyNYSE:COXCox Comm CL A SC23
03/12/201314h56Dow Jones NewsCharter Communications Doesn't Need To Make Buys, CEO Says--UpdateNYSE:COXCox Comm CL A SC23
03/12/201314h37Dow Jones NewsCharter CEO: Charter Doesn't Need Acquisitions to Be Successful -CNBCNYSE:COXCox Comm CL A SC23
26/11/201307h50GlobeNewswire Inc.Nicox establishes commercial operations in Italy through acquisition of EupharmedNYSE:COXCox Comm CL A SC23
12/11/201307h48GlobeNewswire Inc.Nicox launches Sjo(TM) in the US and partners with the Sjogren's Syndrome FoundationNYSE:COXCox Comm CL A SC23
04/11/201307h35GlobeNewswire Inc.Nicox holds first ophthalmology Scientific Advisory Board and attends AAO 2013NYSE:COXCox Comm CL A SC23
30/10/201307h33GlobeNewswire Inc.Nicox reports financial results for the nine months to September 2013NYSE:COXCox Comm CL A SC23
27/09/201314h12GlobeNewswire Inc.Nicox attends Vision Expo West 2013 in Las VegasNYSE:COXCox Comm CL A SC23
11/09/201307h37GlobeNewswire Inc.Nicox Receives Positive Opinion for European Orphan Drug Designation for Naproxcinod for the Treatment of Duchenne Muscular D...NYSE:COXCox Comm CL A SC23
 Showing the most relevant articles for your search:NYSE:COX